Renal insufficiency Trials in Kiel, Germany
Conditions / Renal insufficiency / Kiel, Germany
Renal insufficiency has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00765830 | Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) | COMPLETED | PHASE3 |
| NCT03235375 | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects | COMPLETED | PHASE1 |
| NCT05718648 | A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems | COMPLETED | PHASE1 |
| NCT02320045 | Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects | COMPLETED | PHASE1 |
| NCT05718843 | A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems | COMPLETED | PHASE1 |
| NCT01957657 | Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients | TERMINATED | PHASE1 |
| NCT03189498 | A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function | COMPLETED | PHASE1 |
| NCT03302091 | A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body | COMPLETED | PHASE1 |
| NCT02894385 | Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201) | COMPLETED | PHASE1 |
| NCT02096718 | Afatinib in Subjects With Kidney Dysfunction | COMPLETED | PHASE1 |